CEO Susan Cantrell previews AMCP Nexus 2026, discussing AI, drug pricing, emerging therapies, and a decade of change in managed care pharmacy.
|Articles|October 25, 2012
CHEST 2012 Slideshow
Check out photos from this year's conference in Atlanta, GA, which took place from October 20-25. The meeting was held at the Georgia World Congress Center, which sits between CNN headquarters and the Georgia Dome.
Advertisement
Check out photos from this year's conference in Atlanta, GA, which took place from October 20-25. The meeting was held at the Georgia World Congress Center, which sits between CNN headquarters and the Georgia Dome.
Advertisement
Related to this article
Jennifer Flythe, MD, MPH, discusses individualizing dialysis volume management and why guideline-directed therapy use lags in advanced CKD.
Povetacicept reduced proteinuria by 52% vs 4.3% with placebo at week 36 in adults with IgA nephropathy in the phase 3 RAINIER trial’s interim analysis.
Outpatient dialysis for unfunded patients with ESKD cut ED reliance and costs, while church-based CKD screening improved blood pressure.
At ASN Kidney Week 2026, nephrologists said value-based kidney models improved dialysis starts, but payment cuts and MA growth are pushing practices out.
At IDWeek 2026, IDSA and HIVMA leaders and clinician advocates outline how stories, relationships, and bipartisan outreach shape ID and HIV policy.
At IDWeek 2026, Atul Gawande, MD, MPH, said USAID cuts are costing lives but that the field is "not back at square one."
About 9% of adults hospitalized with RSV died in the hospital or within 30 days of discharge, according to preliminary data presented at IDWeek 2026.
Advertisement
Advertisement
Trending on AJMC
1
Merck, Moderna Cancer Vaccine Cuts Melanoma Recurrence Risk by 42%
2
Povetacicept Cuts Proteinuria by 52% in IgA Nephropathy at Week 36
3
Nephrologists Weigh Wins, Losses From 5 Years of Value-Based Kidney Care
4
Dialysis Access, Church CKD Screening Address Kidney Care Inequities
5